Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
Stock Ideas
ETF Research Tools
ETF Center
ETF Screener
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Portfolio
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
More...
Plans
News
Smart Portfolio
Expert Center
Ideas
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Stock Ideas
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETFs
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Dividends
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto
Crypto Center
Bitcoin
Ethereum
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Portfolio
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
News
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
More
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing
GSK
Stock Latest News
Market News
Pfizer Stock (NYSE:PFE) – New FDA Approval Could Stop Its Drop
4d ago
GSK
PFE
The Fly
GSK Pharma call volume above normal and directionally bullish
1M ago
GSK
The Fly
Agenus up 4% after FDA approves GSK’s Arexvy RSV vaccine
1M ago
GSK
AGEN
The Fly
GSK reports FDA approves Arexvy RSV vaccine for older adults
1M ago
GSK
The Fly
GSK reports Q1 adjusted EPS 37.0p vs 32.3p last year
1M ago
GSK
The Fly
GSK says EMA validates marketing authorization application for Jemperli
1M ago
GSK
The Fly
Bellus Health cut to Sector Perform at RBC Capital on GSK deal
2M ago
BLU
GSK
The Fly
GSK to acquire Bellus Health for $14.75 per share
2M ago
BLU
GSK
Market News
Bellus Health Surges after Acquisition by GSK for $2 Billion
2M ago
BLU
GSK
The Fly
GSK reports EAGLE-2 and EAGLE-3 phase III trials met primary endpoint
2M ago
GSK
The Fly
Return of Adaptimmune assets complements TCR pipeline, says Guggenheim
2M ago
GSK
ADAP
The Fly
Adaptimmune taking back PRAME and NY-ESO target programs from GSK
2M ago
GSK
ADAP
The Fly
GSK unit ordered to pay AstraZeneca royalties on Zejula sales, Reuters says
2M ago
AZN
GSK
The Fly
Scynexis price target raised to $9 from $8 at Guggenheim
2M ago
GSK
SCYX
The Fly
Liquidia enters new, non-exclusive license agreement with GSK
2M ago
GSK
LQDA
The Fly
‘Lots to like’ about Scynexis post-Q4, GSK deal, says Cantor Fitzgerald
2M ago
GSK
SCYX
The Fly
GSK, PathAI collaborate on NASH Phase 2b clinical trial
2M ago
GSK
Market News
SCYNEXIS Skyrockets on Teaming Up With GSK for Fungal Treatment
2M ago
GSK
SCYX
The Fly
Scynexis, GSK announce exclusive agreement to commercialize, develop Brexafemme
2M ago
GSK
SCYX
The Fly
AnaptysBio ‘encouraged’ by GSK phase 3 trial results
2M ago
GSK
ANAB
The Fly
GSK says Phase III Ruby trial demonstrates Jemperli plus chemotherapy potential
2M ago
GSK
The Fly
GSK Pharma put volume heavy and directionally bearish
2M ago
GSK
Show More
You need to enable JavaScript to run this app.